- Published at
- by smallcaps.com.au
mixed
mixed
News for Adherium Limited (ADR.AX)
- Published at
- by smallcaps.com.au
positivepositiveAdherium partners with AstraZeneca for Hailie Smartinhaler clinical trial
Digital health solutions specialist Adherium (ASX: ADR) is celebrating news that global biopharmaceutical giant AstraZeneca has selected its Hailie- Published at
- by globenewswire.com
positivepositiveDigital Biomarkers Market is set to hit USD 24.3 billion by 2033, driven by the rising prevalence of chronic diseases
Continuous advancements in digital health technologies, such as wearable devices, mobile apps, and sensors, are driving the growth of the digital...- Published at
- by globenewswire.com
positivepositiveGlobal Smart Inhalers Market to Surpass 51.85 Billion by 2030 Driven by Increasing Prevalence of Chronic Respiratory Diseases
SkyQuest projects that the global smart inhalers market will attain a value of USD 51.85 billion by 2030, with a CAGR of 19.8% during the forecast period...- Published at
- by globenewswire.com
mixedmixedSmart Inhalers Market Will Reach US$ 235.7 Million by 2033, By Persistence Market Research
Global Smart Inhalers Market to grow at 10.2% CAGR by 2033. Stakeholders prioritize respiratory disorder treatment costs. ...- Published at
- by themarketherald.com.au
neutralneutralAdherium CEO Rick Legleiter resigns
Adherium (ASX:ADR) has announced the resignation of its Chief Executive Officer, Rick Legleiter.- Published at
- by themarketherald.com.au
mixedmixedASX Today: Stocks to watch on Tuesday
The ASX is set to fall with futures down 0.28 per cent near 8:30 am AEDT this morning.- Published at
- by investing.com
positivepositiveASX stocks see significant shifts following mining discoveries and tech trials By Investing.com
ASX stocks see significant shifts following mining discoveries and tech trials- Published at
- by globenewswire.com
negativenegativeSmart Inhalers Market to Attract Revenues Worth USD 522.45 Million by 2032 at 16.16% CAGR - Report by The Brainy Insights
Global smart inhalers market size is anticipated to grow from USD 116.81 million to USD 522.45 million in 10 years. Patients with chronic respiratory...- Published at
- by globenewswire.com
mixedmixedConnected Drug Delivery Devices Market Set to Reach USD 2,980.9 Million by 2032, Fueled by Personalized Medicine Trends
The rising popularity of connected drug delivery devices is driving the growth in demand for home healthcare. These devices provide convenience and...- Published at
- by stockhead.com.au
mixedmixedCheck Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?
Telehealth, mental health and aged care stocks rallied on Wednesday following the Budget announcement which include billions for healthcare.- Published at
- by stockhead.com.au
mixedmixedRise and Shine: Everything you need to know about the ASX before it opens
The 5 stocks set to pop as lithium bottoms, some Small Industrials bargains, and is iron ore flattering to deceive?- Published at
- by stockhead.com.au
mixedmixedCLOSING BELL: The ASX dips while we ‘hurry up and wait’ to see what The Budget holds
It's been relatively quiet ahead of tonight's Federal Budget, except for Voltaic's 188% jump on hugely promising lithium results.- Published at
- by stockhead.com.au
mixedmixedASX Small Caps Lunch Wrap: Who else is crying out for some decent proofreaders this week?
The ASX has dipped 0.3% this morning ahead of tonight's Federal Budget, but three Small Caps are having absolute belters despite the slow day.- Published at
- by stockhead.com.au
mixedmixedClosing Bell: ASX ends four-day losing streak, another explorer reports a clay rare earths find
The S&P ASX 200 has ended a three day losing streak closing up 0.37%, while Codrus Metals (ASX:CDR) reports a rare earths find.- Published at
- by stockhead.com.au
mixedmixedASX Small Caps Lunch Wrap: Which colossal moron is looking good for Canadian Small Business Owner of the Year?
After a heart-stopping jolt, the market was flat at lunchtime, and Codrus is leading the Small Caps race, up 40% on news of a solid TREO find.- Published at
- by stockhead.com.au
mixedmixedRise and Shine: Everything you need to know before the ASX opens
A commodity masterclass with Far East Capital's Warwick Grigor, why coal's a payer and where are all the female small cap CEOs?- Published at
- by stockhead.com.au
mixedmixedCLOSING BELL: The ASX goes down, the Goldies go up, because that’s the way of the world
The ASX has fallen 1.1%, despite a mini gold rush and a major Greentech Metals climb of +165% on news of stunning copper assays.- Published at
- by stockhead.com.au
mixedmixedASX Small Caps Lunch Wrap: Who has most definitely stopped the music this morning?
The ASX lost ground this morning, after banking jitters hit Wall Street and Aussies woke up to the memory of yesterday's RBA donkey-punch.- Published at
- by stockhead.com.au
mixedmixedTop 10 at 10: Copper finds and impressive March quarter results
MoneyMe (ASX:MME) delivered $61m in gross revenue for the March quarter (up 75% on pcp) and is ahead of its target of >$220m for FY23.